Corroborating the lacking predictive potential of anti- EZH2 antibodies regarding the EZH2 mutational status in FL as well as DLBCL [9, 26], we found the immunohistochemical expression of EZH2 to be non-specific concerning differential diagnostic considerations. Here, EZH2 is linked to diffuse large B-cell lymphoma.